Edge Therapeutics, Inc. (36) | Uncategorized (7)
Recent Contracts
-
PDS Biotechnology Corporation 2019 Inducement Plan, as amended
(Filed With SEC on May 18, 2022)
-
Option Agreement with University of Georgia Research Foundation, Inc. effective as of October 25, 2021
(Filed With SEC on March 31, 2022)
-
PDS Biotechnology Corporation 2019 Inducement Plan, as amended
(Filed With SEC on December 9, 2020)
-
Description of Securities
(Filed With SEC on March 27, 2020)
-
Offer Letter, dated February 1, 2019, by and between PDS Biotechnology Corporation and Lauren V. Wood, M.D
(Filed With SEC on August 1, 2019)
-
PDS Biotechnology Corporation 2019 Inducement Plan
(Filed With SEC on June 20, 2019)
-
Letter Agreement, dated as of February 3, 2019, by and among Edge Therapeutics, Inc., PDS Biotechnology Corporation and Brian A. Leuthner
(Filed With SEC on February 4, 2019)
